LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | R406 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 4113 | 5667 | 0.7257 | 0.6366 |
MCF7 | Pictilisib | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1289 | 5667 | 0.2274 | -0.0234 |
MCF7 | Gefitinib | 3.33 | uM | LJP6 | 72 | hr | 1389 | 5503 | 5667 | 0.9710 | 0.9615 |
MCF7 | Geldanamycin | 3.33 | uM | LJP5 | 72 | hr | 1389 | 1257 | 5667 | 0.2219 | -0.0307 |
MCF7 | Geldanamycin | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1217 | 5667 | 0.2147 | -0.0402 |
MCF7 | GSK1059615 | 3.33 | uM | LJP5 | 72 | hr | 1389 | 1373 | 5667 | 0.2422 | -0.0038 |
MCF7 | GSK1059615 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1711 | 5667 | 0.3019 | 0.0752 |
MCF7 | GSK1904529A | 3.33 | uM | LJP6 | 72 | hr | 1389 | 2829 | 5667 | 0.4991 | 0.3365 |
MCF7 | Omipalisib | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1081 | 5667 | 0.1908 | -0.0718 |
MCF7 | GSK 690693 | 3.33 | uM | LJP5 | 72 | hr | 1389 | 2936 | 5667 | 0.5180 | 0.3615 |
MCF7 | GW843682X | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1488 | 5667 | 0.2627 | 0.0233 |
MCF7 | HG-5-113-01 | 3.33 | uM | LJP5 | 72 | hr | 1389 | 1646 | 5667 | 0.2904 | 0.0600 |
MCF7 | HG-5-88-01 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1909 | 5667 | 0.3369 | 0.1217 |
MCF7 | Imatinib | 3.33 | uM | LJP6 | 72 | hr | 1389 | 5850 | 5667 | 1.0322 | 1.0427 |
MCF7 | JNK-9L | 3.33 | uM | LJP6 | 72 | hr | 1389 | 957 | 5667 | 0.1690 | -0.1008 |
MCF7 | JW-7-24-1 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 2028 | 5667 | 0.3578 | 0.1493 |
MCF7 | Lapatinib | 3.33 | uM | LJP6 | 72 | hr | 1389 | 5083 | 5667 | 0.8969 | 0.8634 |
MCF7 | LDN-193189 | 3.33 | uM | LJP5 | 72 | hr | 1389 | 3320 | 5667 | 0.5858 | 0.4514 |
MCF7 | Linifanib | 3.33 | uM | LJP6 | 72 | hr | 1389 | 4764 | 5667 | 0.8406 | 0.7888 |
MCF7 | Linsitinib | 3.33 | uM | LJP5 | 72 | hr | 1389 | 3143 | 5667 | 0.5545 | 0.4099 |
MCF7 | Mitoxantrone | 3.33 | uM | LJP5 | 72 | hr | 1389 | 626 | 5667 | 0.1105 | -0.1782 |
MCF7 | Mitoxantrone | 3.33 | uM | LJP6 | 72 | hr | 1389 | 555 | 5667 | 0.0979 | -0.1949 |
MCF7 | MK2206 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 2211 | 5667 | 0.3901 | 0.1921 |
MCF7 | Neratinib | 3.33 | uM | LJP5 | 72 | hr | 1389 | 3216 | 5667 | 0.5675 | 0.4271 |
MCF7 | Nilotinib | 3.33 | uM | LJP5 | 72 | hr | 1389 | 5583 | 5667 | 0.9851 | 0.9803 |